ArticleScientific reports2025
The impact of radical hepatectomy on prognosis of patients with hepatic alveolar echinococcosis complicated with microvascular invasion.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To investigate the effect of radical hepatectomy on the prognosis of patients with hepatic alveolar echinococcosis (HAE) complicated with microvascular invasion (MVI). HAE patients who underwent radical hepatectomy at the Echinococcosis Diagnosis and Treatment Center of Qinghai Provincial People's Hospital from January 2014 to December 2020 were collected in this study according to the inclusion and exclusion criteria. The clinical data of the patients were collected and analyzed. According to the surgical method, the patients were divided into anatomical hepatectomy group (Anatomical group) and non-anatomical hepatectomy group (Non-anatomical group). Kaplan-Meier survival analysis was used to compare the 5-year recurrence-free survival (RFS) between the two groups. A total of 375 patients were enrolled in the study (with 185 in Anatomical group and 190 in Non-anatomical group). The results of clinicopathological data analysis showed that compared with the Non-anatomical group, the patients in the Anatomical group had less intraoperative blood loss and blood transfusion, and a lower postoperative recurrence rate (all P < 0.05). The survival analysis results showed that the overall survival of the enrolled patients was 92.9%. Compared with the Non-anatomical group, the 5-year RFS of the Anatomical group was higher (98% vs. 87.7%, P < 0.05). Besides, In the Anatomical group, the 5-year RFS of patients with negative MVI was better than that of patients with positive MVI (100% vs. 94.5%, P < 0.05). Similarly, in the Non-anatomical group, the 5-year RFS of patients with negative MVI was also superior to that of patients with positive MVI (99% vs. 75.8%, P < 0.05). In addition to surgical methods, MVI may be another important factor affecting the 5-year RFS of patients with HAE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.